Related Experiment Video
Updated: Jun 13, 2026
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Laparo-endoscopic single site (LESS) robotic radical prostatectomy in an Asian man with prostate cancer: an initial
Sunai Leewansangtong1, Puttipannee Vorrakitkatorn, Teerapon Amornvesukit
1Division of Urology, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. sislt@mahidol.ac.th
Objective:
To report the feasibility of laparo-endoscopic single site (LESS) robotic radical prostatectomy performed in Asian man.
Material And Method:
A 71 year-old man with adenocarcinoma of prostate presented at Faculty of Medicine Siriraj Hospital, Bangkok. Prostate-specific antigen level was 16.5 ng/ml and digital rectal examination approximately showed 30 gram prostate with nodule in both lobes. No clinical metastasis was found. Leuprorelin acetate and 50 mg of bicalutamide were used for 3 months. The patient's body mass index was 22 and healthy. With the consent form signed, laparo-endoscopic single site (LESS) robotic radical prostatectomy was performed with the robot daVinci S system.
Results:
The total operative time was 335 minutes; docking time was 12 minutes; console time was 275 minutes. The estimate blood loss was 250 ml and no blood transfusion required. No intraoperative or postoperative complication was found. Jackson drain was removed within 60 hours after surgery. The patient was discharged from the hospital within 84 hours after surgery. The urethral catheter was removed within 14 days after surgery.
Conclusion:
Laparo-endoscopic single site (LESS) robotic radical prostatectomy is feasible to be performed In the initial experience, patient selection is required.
More Related Videos
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025